L

Lantheus Holdings
D

LNTH

77.960
USD
0.10
(0.13%)
مغلق
حجم التداول
41,472
الربح لكل سهم
7
العائد الربحي
-
P/E
22
حجم السوق
5,393,727,775
أصول ذات صلة
ABT
ABT
-1.740
(-1.30%)
132.260 USD
BSX
BSX
0.210
(0.21%)
101.710 USD
EW
EW
-1.530
(-2.05%)
73.280 USD
ISRG
ISRG
-7.05
(-1.36%)
511.91 USD
MDT
MDT
-1.740
(-1.98%)
86.210 USD
MTD
MTD
-32.47
(-2.74%)
1,150.58 USD
PODD
PODD
-2.24
(-0.73%)
304.32 USD
SYK
SYK
-3.85
(-1.02%)
373.31 USD
TMO
TMO
-14.95
(-3.69%)
390.27 USD
المزيد
الأخبار المقالات

العنوان: Lantheus Holdings

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.